<DOC>
	<DOCNO>NCT01686581</DOCNO>
	<brief_summary>This observational study describe long term use Onabotulinumtoxin A ( BOTOX® ) prescribe physician headache prophylaxis adult chronic migraine . All treatment decision lie physician .</brief_summary>
	<brief_title>An Observational Study BOTOX® Headache Prophylaxis Chronic Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Prescribed BOTOX® prophylaxis headache Received treatment botulinum toxin Type A serotype last 26 week Current participation Allergan 's Botox Chronic Migraine PostAuthorisation Safety Study ( protocol 191622110 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>